Transgenic augmentation of erythroferrone in mice ameliorates anemia in adenine-induced chronic kidney disease

By afschroeder • August 8, 2025

Czaya B, Olivera JD, Zhang M, Lundin A, Castro Andrade CD, Jung G, Hanudel MR, Nemeth E, Ganz T. Transgenic augmentation of erythroferrone in mice ameliorates anemia in adenine-induced chronic kidney disease. JCI Insight. 2025 Aug 7:e190018. doi: 10.1172/jci.insight.190018. Epub ahead of print. PMID: 40773297.

Tags: Bone marrow differentiation, Chronic kidney disease, hematology, nephrology, Post Doc, Publications, Pulmonary, Critical Care & Sleep Medicine

Related Posts

Blinatumomab Nonresponse Correlates with Poor Survival After Brexucabtagene

Srinagesh HK, Gupta VK, Zhang A, Grunwald MR, Connor MP, Kota VK, Boccucci J, Ulrickson ML, Pradeep R, Hill LC, Tsai SB, O'Connor TE, Sandhu[...]

Reperfusion Strategies for Acute Pulmonary Embolism: Design and Rationale of RECONNECT-PE – a Living Systematic Review and Meta-analysis

Farmakis IT, Binder H, Chopard R, Christodoulou KC, Evrenoglou T, Fengler K, Giri J, Hobohm L, Jaber WA, Klok FA, Kocka V, Kroupa J, Kucher[...]

Neoadjuvant Stereotactic Body vs. Conventionally Fractionated Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Propensity Score-Matched Analysis

Shimizu T, Zheng S, Maeda S, Link J, Deranteriassian A, Premji A, King J, Girgis M, Hines OJ, Wainberg Z, Raldow A, He J, Burns[...]